HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Non-homologous recombination between Alu and LINE-1 repeats caused a 430-kb deletion in the dystrophin gene: a novel source of genomic instability.

Abstract
Although large deletions in the dystrophin gene have been identified in more than two-thirds of Duchenne and Becker muscular dystrophy patients, the molecular mechanisms that lead to the generation of these deletions are largely unknown. Here, Alu and LINE-1 (L1) repetitive elements were shown to be present at one or other of the two ends, respectively, of a 430-kb deletion in the dystrophin gene. The breakpoint of the deletion, which stretches from exons 2 to 7, was defined more precisely by polymerase chain reaction (PCR) walking on introns 1 and 7. Finally, the region containing the breakpoint was amplified as a fragment of more than 10kb. Sequencing of the deletion endpoint revealed the presence of an Alu sequence in intron 1, 25 kb downstream from the 3' end of exon 1 that was joined directly to an L1 sequence in intron 7, 4.5kb downstream from the 3' end of exon 7. The deletion was calculated to be 430kb. To our knowledge, this is a novel recombination event joining non-homologous Alu and L1 repeats, and is the largest known intrachromosomal deletion that is thought to involve repetitive genetic elements. Sequence characteristics around the breakpoint are discussed.
AuthorsR Suminaga, Y Takeshima, K Yasuda, N Shiga, H Nakamura, M Matsuo
JournalJournal of human genetics (J Hum Genet) Vol. 45 Issue 6 Pg. 331-6 ( 2000) ISSN: 1434-5161 [Print] England
PMID11185740 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dystrophin
Topics
  • Alu Elements (genetics)
  • Base Sequence
  • Child
  • Dystrophin (genetics)
  • Gene Deletion
  • Humans
  • Long Interspersed Nucleotide Elements (genetics)
  • Male
  • Molecular Sequence Data
  • Muscular Dystrophy, Duchenne (genetics)
  • Recombination, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: